Bradley E. Lerman net worth and biography

Bradley Lerman Biography and Net Worth

Director of McKesson

Mr. Lerman served as the executive vice president and chief legal officer of Starbucks Corporation from 2023 to 2025, where he led the legal and regulatory affairs, global security, and ethics and compliance functions. Mr. Lerman also served as the senior vice president, general counsel, and corporate secretary of Medtronic plc, an American medical device company, from 2014 to 2022. Prior to Medtronic, Mr. Lerman served as executive vice president, general counsel and corporate secretary for the Federal National Mortgage Association (Fannie Mae). Previous to Fannie Mae, he served as senior vice president, associate general counsel and chief litigation counsel for Pfizer. Mr. Lerman also served as a litigation partner at Winston & Strawn LLP in Chicago and as an assistant U.S. attorney in the Northern District of Illinois. He received a law degree from Harvard Law School and his bachelor’s degree in economics from Yale University.

What is Bradley E. Lerman's net worth?: The estimated net worth of Bradley E. Lerman is at least $64.39 million as of October 8th, 2020. Mr. Lerman owns 74,242 shares of McKesson stock worth more than $64,388,231 as of August 17th. This net worth estimate does not reflect any other investments that Mr. Lerman may own. Learn More about Bradley E. Lerman's net worth.
How do I contact Bradley E. Lerman?: The corporate mailing address for Mr. Lerman and other McKesson executives is 6555 STATE HWY 161, IRVING TX, 75039. McKesson can also be reached via phone at (972) 446-4800 and via email at [email protected]. Learn More on Bradley E. Lerman's contact information.
Has Bradley E. Lerman been buying or selling shares of McKesson?: During the past quarter, Bradley E. Lerman has sold $268,591.33 in McKesson stock. Most recently, Bradley E. Lerman sold 301 shares of the business's stock in a transaction on Monday, August 10th. The shares were sold at an average price of $892.33, for a transaction totalling $268,591.33. Learn More on Bradley E. Lerman's trading history.
Who are McKesson's active insiders?: McKesson's insider roster includes Nancy Avila (EVP), James Beer (CFO), Kevin Emerson (CAO), Tracy Faber (EVP), Nancy Flores (EVP), John Hammergren (Chairman), B Jr (CAO), Marie Knowles (Director), Erin Lampert (SVP), Michele Lau (EVP), Bradley Lerman (Director), Maria Martinez (Director), Sundeep Reddy (SVP), Thomas Rodgers (EVP), Susan Salka (Director), Lori Schechter (EVP), LeAnn Smith (EVP), Brian Tyler (CEO), Brian Tyler (CEO), and Britt Vitalone (CFO). Learn More on McKesson's active insiders.
Are insiders buying or selling shares of McKesson?: During the last twelve months, insiders at the sold shares 16 times. They sold a total of 45,176 shares worth more than $34,976,088.93. The most recent insider tranaction occured on August, 10th when Director Bradley E Lerman sold 301 shares worth more than $268,591.33. Insiders at McKesson own 0.1% of the company. Learn More about insider trades at McKesson.
Information on this page was last updated on 8/10/2026.

Bradley E. Lerman Insider Trading History at McKesson

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/10/2026	Sell	301	$892.33	$268,591.33

Bradley E. Lerman Buying and Selling Activity at McKesson

McKesson Company Overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Today's Range

Now: $864.49

$859.49

$879.34

50 Day Range

MA: $813.45

$745.12

$901.66

2 Week Range

Now: $864.49

$667.50

$999.00

Volume

332,685 shs

Average Volume

949,158 shs

Market Capitalization

$100.79 billion

P/E Ratio

23.13

Dividend Yield

0.38%

Beta

0.3